Ascendis Pharma A/S vs Global E Online Ltd — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Global E Online Ltd trades at $43 (market cap $6.87B). The key difference: Ascendis Pharma A/S is far larger — about 2.4× Global E Online Ltd's market cap, and Global E Online Ltd is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| ASND | GLBE | |
|---|---|---|
Market Cap | $16.67B | $6.87B |
Sector | Health | Technology |
52-Week High | $277.18 | $42.32 |
52-Week Low | $189.74 | $27.54 |
Enterprise Value | $17.04B | $6.34B |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →